↓ Skip to main content

Pancreatic enzyme replacement therapy for people with cystic fibrosis

Overview of attention for article published in this source, October 2014
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
9 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pancreatic enzyme replacement therapy for people with cystic fibrosis
Published by
John Wiley & Sons, Ltd, October 2014
DOI 10.1002/14651858.cd008227.pub2
Pubmed ID
Authors

Somaraju, Usha Rani, Solis-Moya, Arturo

Abstract

Most people with cystic fibrosis (80% to 90%) need pancreatic enzyme replacement therapy to prevent malnutrition. Enzyme preparations need to be taken whenever food is taken, and the dose needs to be adjusted according to the food consumed. A systematic review on the efficacy and safety of pancreatic enzyme replacement therapy is needed to guide clinical practice, as there is variability between centres with respect to assessment of pancreatic function, time of commencing treatment, dose and choice of supplements.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
Netherlands 1 1%
South Africa 1 1%
Unknown 90 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 14%
Researcher 13 14%
Student > Master 13 14%
Student > Bachelor 11 12%
Librarian 6 6%
Other 17 18%
Unknown 21 22%
Readers by discipline Count As %
Medicine and Dentistry 29 31%
Nursing and Health Professions 6 6%
Social Sciences 6 6%
Biochemistry, Genetics and Molecular Biology 4 4%
Economics, Econometrics and Finance 4 4%
Other 21 22%
Unknown 24 26%